Medioint Lifescience Private Limited, a active private limited company, was established on 03 August 2020 in Dhar, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MP2020PTC052158. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.75 Cr and a paid-up capital of ₹2.63 Cr.
It upholds a compliant status. Employing 17 professional, Its leadership includes Mukesh Kumar Joshi (Director), Arvindkumar Dillu Saroj (Director), Satish Ramrao Pawar (Director). Past directors included Attaullah Tabarak Ansari. It holds ₹9.86 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 260-A, Sector-Iii, Industrial Growth Center, Dhar, Madhya Pradesh, 454775.
U24230MP2020PTC052158
052158
03 August 2020
₹2.75 Cr
₹2.63 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Medioint Lifescience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Kumar Joshi | Director | 03 Aug 2020 | Current |
| Arvindkumar Dillu Saroj | Director | 03 Aug 2020 | Current |
| Satish Ramrao Pawar | Director | 03 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 May 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medioint Lifescience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 391833.23% increase. The company also saw a substantial fall in profitability, with a 8543.86% decrease in profit. The company's net worth moved up by a moderate rise of 5.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Medioint Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹98,619,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2025 | Sidbi | ₹2.80 Cr | Open |
| 11 Aug 2023 | Others | ₹3.00 M | Open |
| 24 Feb 2023 | Others | ₹1.76 Cr | Open |
| 29 Oct 2021 | Others | ₹1.50 Cr | Open |
| 27 Oct 2021 | Others | ₹3.50 Cr | Open |
Explore comprehensive loan charge details -
Medioint Lifescience has a workforce of 17 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medioint Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medioint Lifescience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Sidbi amounted to Rs. 2.80 Cr with Charge ID 101080948 was registered on 27 Mar 2025. was documented.
The activity Medioint Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Medioint Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
A charge with Others amounted to Rs. 0.30 Cr with Charge ID 100783710 was registered on 11 Aug 2023. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.76 Cr with Charge ID 100723849 was registered on 24 Feb 2023. was completed.
The activity A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100499197 was registered on 29 Oct 2021. was completed.
The CIN of Medioint Lifescience Private Limited is U24230MP2020PTC052158.
Medioint Lifescience Private Limited is headquartered at Plot No. 260-A, Sector-Iii, Industrial Growth Center, Dhar, Madhya Pradesh, 454775.
Medioint Lifescience Private Limited was incorporated on 03 August 2020.
The current directors of Medioint Lifescience Private Limited are
The primary industry of Medioint Lifescience Private Limited is Manufacturing.
Medioint Lifescience Private Limited is unlisted.
The authorized capital of Medioint Lifescience Private Limited is ₹2.75 Cr, and the paid-up capital is ₹2.63 Cr.
The compliance status of Medioint Lifescience Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX